Journal of Virus Eradication (Dec 2022)
OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab
- B. Varco-Merth,
- M. Chaunzwa,
- D. Duell,
- A. Marenco,
- S. Docken,
- J. Smedley,
- M.K. Axthelm,
- S.G. Hansen,
- M.P. Davenport,
- J.D. Estes,
- B. Keele,
- J.D. Lifson,
- S.R. Lewin,
- A.A. Okoye,
- L.J. Picker
Affiliations
- B. Varco-Merth
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- M. Chaunzwa
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- D. Duell
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- A. Marenco
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- S. Docken
- Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia
- J. Smedley
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- M.K. Axthelm
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- S.G. Hansen
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- M.P. Davenport
- Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia
- J.D. Estes
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- B. Keele
- AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD, Untied States
- J.D. Lifson
- AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD, Untied States
- S.R. Lewin
- The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Victoria, Australia
- A.A. Okoye
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- L.J. Picker
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- Journal volume & issue
-
Vol. 8
p. 100153